Primary Site >> Liver Cancer

Gene >> KALRN

Journal: Srp Arh Celok Lek. 1995 Sep-Oct;123(9-10):240-3.
Title: [Biochemistry in liver cancer].
Author: Kostic, N|Dzelebdzic, J|Miljkovic, D|Isajlovic, Z
PMID: 17974439
Journal: Cancer Lett. 2016 Feb 28;371(2):205-13.
Title: A combination of sorafenib and SC-43 is a synergistic SHP-1 agonist duo to advance hepatocellular carcinoma therapy.
Author: Chao, Tzu-I|Tai, Wei-Tien|Hung, Man-Hsin|Tsai, Ming-Hsien|Chen, Min-Hsuan|Chang, Mao-Ju|Shiau, Chung-Wai|Chen, Kuen-Feng
PMID: 26679051
Journal: J Clin Diagn Res. 2017 Sep;11(9):OC01-OC05.
Title: Cirrhosis of Liver and Diabetes Mellitus: The Diabolic Duo?
Author: Ramachandran, Thazhath Mavali|Rajneesh, Aninchent Harayil Rajan|Zacharia, George Sarin|Adarsh, Rajendran P
PMID: 29207749
Journal: BMC Cancer. 2018 Jun 7;18(1):640.
Title: Deep sequencing of human papillomavirus positive loco-regionally advanced oropharyngeal squamous cell carcinomas reveals novel mutational signature.
Author: Gronhoj, Christian|Jensen, David H|Agander, Tina|Kiss, Katalin|Hogdall, Estrid|Specht, Lena|Bagger, Frederik Otzen|Nielsen, Finn Cilius|von Buchwald, Christian
PMID: 29879932
Journal: Curr Opin Pharmacol. 2018 Sep 14;43:93-98.
Title: The gut-liver axis in hepatocarcinoma: a focus on the nuclear receptor FXR and the enterokine FGF19.
Author: Piglionica, Marilidia|Cariello, Marica|Moschetta, Antonio
PMID: 30223181